Welcome to our dedicated page for STEPAN CO SEC filings (Ticker: SCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Stepan Company filings document the regulatory record for a specialty and intermediate chemicals manufacturer whose common stock trades on the New York Stock Exchange under symbol SCL. Its 8-K filings report operating results, dividend declarations, material-event disclosures, capital-structure information and exit or disposal activities tied to manufacturing and efficiency initiatives.
Stepan proxy and annual-meeting filings cover director elections, advisory compensation votes, auditor ratification, executive compensation governance and benefit-plan matters. The filing record also includes disclosure on restructuring charges, asset write-downs, decommissioning costs and other governance or financial matters reported through current reports and proxy materials.
Stepan Company (SCL) reported equity awards granted to Ruben D. Velasquez, who is the company’s Vice President and Chief Financial Officer. On 08/08/2025 he acquired 2,037 performance shares, 4,074 restricted stock units (RSUs) and 5,714 stock appreciation rights (SARs). The SARs show a stated exercise/conversion price of $49.09. Each performance share and each RSU represents a contingent right to receive one share of common stock, and the reported acquisition amounts are recorded at a price of $0.
The performance shares vest upon certification of Stepan achieving specified performance goals for the period ending December 31, 2027. The RSUs and SARs become exercisable beginning 08/08/2026; RSUs vest ratably over three years from that date, and the SARs expire on 08/08/2035. All reported holdings are shown as direct beneficial ownership.
Stepan Co. (SCL) Form 4 filed 08/06/25 details insider activity by Director F. Quinn Stepan Jr. on 08/04-05/25.
- Sales: 6,300 shares at $49.962 and 3,700 shares at $50.489 (≈10,000 total; ≈$500k gross).
- Gift: 3,000 shares transferred to joint tenancy with spouse at no cost (Code G).
- Other: 0.615 shares withheld for taxes (Code F) and 2.281 deferred share units converted to stock (Code G/A).
Post-trade direct ownership drops to 159,423 shares, down roughly 6%, while indirect interests total ≈429 k shares across family LLCs, trusts, ESOPs and estates. The director also holds 63,405 deferred share units plus 43,167 units in his father’s deferred plan.
No Rule 10b5-1 trading plan box was marked, suggesting discretionary transactions. Given the company’s ~22 m share float, the 10 k-share sale is immaterial to liquidity but may be watched as a sentiment signal.
Stepan Company (NYSE: SCL) filed its Q2-25 Form 10-Q. Net sales rose 6.9% YoY to $594.7 million, driven by 8.3% growth in Surfactants and 1.9% in Polymers; Specialty Products advanced 21.5%. Gross profit improved 3.4% to $71.9 million, but operating income slipped 3.8% to $18.0 million as selling and R&D costs increased 6.0%. Higher interest expense (-106% YoY) cut pre-tax earnings 20% to $13.8 million; however, a sharply lower effective tax rate (17.7% vs. 44.7%) lifted net income 19% to $11.3 million, or $0.50 diluted EPS.
For the six-month period, revenue gained 7.2% to $1.19 billion and operating income rose 19% to $46.3 million. Net income reached $31.1 million (+32.6%), translating to $1.36 EPS.
Segment detail (Q2): Polymers profit jumped 26% to $17.2 million on higher volume and price/mix, offsetting declines in Surfactants (-22%) and Specialty Products (-28%). Corporate expense fell 8%.
Balance sheet: Cash fell to $88.9 million (-$10.8 million YTD) as operating cash flow weakened to $18.1 million from $71.1 million. Capex remained elevated at $58.3 million. Total debt increased 5.3% to $658 million after issuing $75 million of 6.17% senior notes; net leverage stands near 1.1× EBITDA. Equity improved to $1.24 billion, aided by a $57 million favorable FX translation adjustment that reduced AOCI.
Other highlights: • Assets of the Philippine surfactant plant ($8.7 million) classified as held for sale.
• Environmental liabilities accrued at $19.5 million (low end of $19.5–$44.9 million range).
• New U.S. tax act (enacted 7-4-25) not yet reflected; management expects no material 2025 impact.
Outlook: Management continues to invest in capacity (capex $58 million YTD) while navigating higher financing costs and mixed segment margins. Sale of the Philippine site and working-capital normalization are expected to support liquidity in 2H-25.
Form 8-K material event: Stepan Company (NYSE: SCL) disclosed the appointment of Ruben Velasquez, age 51, as Vice President & Chief Financial Officer, effective July 15 2025. He succeeds interim CFO Samuel Hinrichsen, who returns to his prior role as Vice President of Finance.
Professional background: Velasquez joins from 3M Company, where he spent 19 years in progressively senior finance roles, most recently serving as Vice President of Global Finance Transformation (2022-2024). His previous posts at 3M included CFO positions for Manufacturing & Supply Chain Operations (2021-2022), Consumer Business (2016-2021), and Electronics Materials Solutions (2013-2016), as well as country CFO roles in Russia and Colombia.
Compensation: • Base salary: $475,000 per year. • Target annual cash incentive: 75 % of base salary. • Initial long-term incentive grant (Aug-2025): $200,000 in restricted stock units, $100,000 in performance shares, and $100,000 in stock appreciation rights, all with standard performance and vesting terms. • Relocation benefits and standard executive perquisites.
Governance disclosures: The filing notes no relationships or related-party transactions under Item 404(a). Appointment terms are not tied to any arrangement with other parties.
Exhibits: 99.1 – press release dated July 14 2025 announcing the appointment; 104 – cover-page Inline XBRL data file.
This leadership change completes the CFO search and places a seasoned multinational executive at the helm of Stepan’s finance organization.
Stepan Co. (SCL) — Form 3 initial insider filing: On 06/20/2025, attorney-in-fact James A. Hart submitted an Initial Statement of Beneficial Ownership on behalf of director Corning F. Painter, covering the event date 06/09/2025.
The filing establishes Painter’s baseline insider status and confirms that he currently owns no direct or indirect shares or derivative securities of Stepan Co. Going forward, any purchase or disposition by the director must be reported on Form 4 within two business days. The disclosure is routine and contains no financial metrics or transactional details that would alter Stepan’s investment outlook.